Strategic Drug Development
166
portfolio_page-template-default,single,single-portfolio_page,postid-166,bridge-core-1.0.4,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.0.9,qode-theme-bridge,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-5.7,vc_responsive
 

Strategic Drug Development

Home > Strategic Drug Development

Strategic Drug Development

MIC helps in the overall end-to-end clinical development of NCE/NBE molecules spanning from designing clinical trial documents; conceptualizing clinical study design, exploring innovative approaches/models for proof-of-concept studies, and most importantly development of clinical development plans and target product profiles.

Strategic Drug Development

  • Development of Clinical Development Plan (CDP)
  • Identification of Target Product Profile (TPP)
  • Scientific Literature Surveillance
  • Scientific consultancy